DJIA 17,001.22 -38.27 -0.22%
NASDAQ 4,538.55 6.45 0.14%
S&P 500 1,988.40 -3.97 -0.20%
market minute promo

Geron Corp (NASDAQ: GERN)



company name or ticker

Why Geron Corporation Shares Were Mauled

Geron shares are turned upside down after updating the status of its imetelstat development program. Is this dip a buying opportunity or all the more reason to hit the exit?

Back to Normalcy at Geron

Geron, Zogenix, Synta Pharmaceuticals, and Pfizer: Today’s Top Health Care Stories

Geron, Zogenix, Synta Pharmaceuticals, and Pfizer could all make health care headlines this morning. Here’s why.

Use Options For a Chance To Buy GERN at a 52% Discount

Geron: A Biotech Stock With Potential For Long-Term Gains

Geron: Where Did The Shares Go?

Update: Week Ending February 15, 2014

Here's Why Geron Has Been So Volatile This Year

Geron's stock has been on a rollercoaster ride in 2014. Here's why.

Geron: Billion-Dollar Drugs And Possibility Of Accelerated Approval

Geron Corporation Announces Closing of its Public Offering of Common Stock and Exercise of Option to

Geron Corporation Announces Closing of its Public Offering of Common Stock and Exercise of Option to Purchase Additional Shares